Condition: Chronic Cholecystitis · Biliary Dyskinesia · Sponsor: Valenta Pharm JSC
This study aims to evaluate the efficacy, safety, and tolerability of the drug 4-MUST at various doses compared to placebo in patients with chronic cholecystitis and biliary dyskinesia
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| State autonomous health care institution "Engels City Clinical Hospital No. 1" | Engel's, Russia | Recruiting |
| Ivanovo Kuvaev Clinical Hospital | Ivanovo, Russia | Recruiting |
| State Budgetary Institution of Healthcare of Moscow "City Polyclinic No. 2 of the Moscow Department of Healthcare" | Moscow, Russia | Recruiting |
| Unimed-C Jsc | Moscow, Russia | Recruiting |
| The State Budgetary Healthcare Institution of the Moscow Region "Moscow Regional Research Clinical Institute named after M.F. Vladimirsky" | Moscow, Russia | Recruiting |
| Limited Liability Company "ErSi Medical" | Novosibirsk, Russia | Recruiting |
| Professors' Clinic LLC. | Perm, Russia | Recruiting |
| Limited Liability Company "Medical Center Eco-Safety" | Saint Petersburg, Russia | Recruiting |
| Limited Liability Company "Energy of Health" | Saint Petersburg, Russia | Recruiting |
| St. Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 117" | Saint Petersburg, Russia | Recruiting |
| Limited Liability Company "Clinic Zvezdnaya" | Saint Petersburg, Russia | Recruiting |
| Limited Liability Company "Meili" | Saint Petersburg, Russia | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06842966